Specifically, intrathecal administration of exogenous endoglin significantly inhibited the activation of microglia and the expression of inflammatory factors in the dorsal horn of the ipsilateral spinal cord induced by SNI, while also reducing peripheral nerve injury-induced hyperalgesia. The gene discussed is ENG; the disease is peripheral nerve injury.